Market LIVE
Published markets; coverage varies by country
Product profile · United States

OMLONTI

 ·  Patent Litigation & Settlement History ↓

IngredientOMIDENEPAG ISOPROPYL
Application typeNDA
Application215092
Product001
Dosage formSOLUTION
RouteOPHTHALMIC
Strength0.002%
Approval date2022-09-22
Marketing statusPrescription
Status event—
ApplicantOCUVEX THERAP
Product source

Current GenericRadar decision

Year2029
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2029-10-13
Patent anchor2029-10-13
Exclusivity anchor2027-09-22
Protection date2039-07-16
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2029. Anchor type: PATENT. Patent anchor: 2029-10-13. Exclusivity anchor: 2027-09-22. Anchor date: 2029-10-13. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
86480972029-10-13DS/DP —YNTRUE_DS
English description not available.
———
86480972029-10-13ORANGE_BOOK —YNTRUE_DS
English description not available.
———
86859862029-10-13DP —NNDP
English description not available.
———
86859862029-10-13ORANGE_BOOK —NNDP
English description not available.
———
101791272035-01-08DP/U U-3454NNDP
English description not available.
———
101791272035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
107025112035-01-08DP/U U-3454NNDP
English description not available.
———
107025112035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
107657502035-01-08DP —NNDP
English description not available.
———
107657502035-01-08ORANGE_BOOK —NNDP
English description not available.
———
111978492035-01-08DP/U U-3454NNDP
English description not available.
———
111978492035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
117937982035-01-08DP/U U-3454NNDP
English description not available.
———
117937982035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
122959462035-01-08DP/U U-3454NNDP
English description not available.
———
122959462035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
94150382035-01-08DP/U U-3454NNDP
English description not available.
———
94150382035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
RE481832035-01-08DP/U U-3454NNDP
English description not available.
———
RE481832035-01-08ORANGE_BOOK U-3454NNDP
English description not available.
———
107740722035-06-10DS —NNDP
English description not available.
———
107740722035-06-10ORANGE_BOOK —NNDP
English description not available.
———
122905112038-12-27U U-3454NNU
English description not available.
———
122905112038-12-27ORANGE_BOOK U-3454NNU
English description not available.
———
116665632039-07-16U U-3454NNU
English description not available.
———
116665632039-07-16ORANGE_BOOK U-3454NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2022-09-222027-09-22English description not available.YY2027-09-22—Source
NCE2022-09-222027-09-22English description not available.YY2027-09-22
NCE
Full coverage date: 2027-09-22
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (15)
TypeDateRoleBasisSource
PATENT2029-10-13CANONICAL_ANCHOREnglish description not available.Source
PATENT2029-10-13HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-01-08FTO_TAILEnglish description not available.Source
PATENT2035-06-10FTO_TAILEnglish description not available.Source
PATENT2038-12-27FTO_TAILEnglish description not available.Source
PATENT2039-07-16FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2029-10-13CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.